Results 61 to 70 of about 134,961 (204)

Peptide transport in Candida albicans and synthetic antifungal agents [PDF]

open access: yes, 1986
These studies have characterized the peptide transport systems of Candida albicans, with a view to the rational design of peptide antifungal agents exploiting the 'smugglin' concept.
Shallow, David A.
core  

A review of recent developments in pharmaceutical chemistry on biological evolution of tetrazole derivatives

open access: yesAl-SalamJournal for Medical Science
This review sums up the developments in the biological activity of tetrazole active derivatives in recent days. Some of the deliberated derivatives of tetrazole are at present actively scientifically studied; some of them have biological activity that ...
Zahraa A. Ketan   +4 more
doaj   +1 more source

Susceptibilities of Candida albicans multidrug transporter mutants to various antifungal agents and other metabolic inhibitors [PDF]

open access: yes, 1996
Some Candida albicans isolates from AIDS patients with oropharyngeal candidiasis are becoming resistant to the azole antifungal agent fluconazole after prolonged treatment with this compound. Most of the C. albicans isolates resistant to fluconazole fail
Ischer, F.   +3 more
core  

ABC transporters and azole susceptibility in laboratory strains of the wheat pathogen Mycosphearella graminicola [PDF]

open access: yes, 2002
Laboratory strains of Mycosphaerella graminicola with decreased susceptibilities to the azole antifungal agent cyproconazole showed a multidrug resistance phenotype by exhibiting cross-resistance to an unrelated chemical, cycloheximide or rhodamine 6G ...
Nistelrooy, J.G.M., Van   +3 more
core   +1 more source

Antifungal pharmacodynamics: Latin America's perspective

open access: yesBrazilian Journal of Infectious Diseases, 2017
The current increment of invasive fungal infections and the availability of new broad-spectrum antifungal agents has increased the use of these agents by non-expert practitioners, without an impact on mortality.
Javier M. Gonzalez   +4 more
doaj   +1 more source

Treatment of onychomycosis with antifungal agents. [PDF]

open access: yes, 2014
Treatment of onychomycosis with antifungal agents.
Mahmoud Ghannoum (179003)   +1 more
core   +1 more source

Hsp90 governs dispersion and drug resistance of fungal biofilms [PDF]

open access: yes, 2011
Fungal biofilms are a major cause of human mortality and are recalcitrant to most treatments due to intrinsic drug resistance. These complex communities of multiple cell types form on indwelling medical devices and their eradication often requires ...
Ramage Gordon   +25 more
core   +1 more source

Aerosolized Delivery of Antifungal Agents [PDF]

open access: yes, 2010
Pulmonary infections caused by Aspergillus species are associated with significant morbidity and mortality in immunocompromised patients. Although the treatment of pulmonary fungal infections requires the use of systemic agents, aerosolized delivery is ...
Schiller, Daryl S.   +4 more
core   +1 more source

In Vitro Antifungal Activity of Essential Oils and Nanoemulsions of Zingiber cassumunar and Cymbopogon citratus Against Planktonic and Biofilm Forms of Malassezia pachydermatis

open access: yesAntibiotics
Malassezia pachydermatis is a yeast pathogen associated with recurrent skin and ear infections in dogs, often complicated by biofilm formation and reduced antifungal susceptibility.
Sirikorn Promcham   +6 more
doaj   +1 more source

Antimicrobial susceptibility testing of dermatophytes - Comparison of the agar macrodilution and broth microdilution tests [PDF]

open access: yes, 1998
Fifty dermatophyte strains, recently obtained from clinical material, belonging to 4 different species were examined for their susceptibility to 5 systemic or topical antimycotic agents using both an agar macrodilution and a broth microdilution test ...
Korting, Hans Christian   +4 more
core   +1 more source

Home - About - Disclaimer - Privacy